Parents with children under five were hopeful that their children would soon be eligible for the Pfizer/BioNTech Covid vaccine, a long awaited moment since the beginning of the COVID-19 pandemic.
Indeed, plans were set for the Food and Drug Administration (FDA) vaccine advisory committee to discuss data recently submitted by Pfizer on February 15, the next step in the process to pave the way for approval for children between 6 months and 4 years old for the vaccine.
